NEOGENOMICS INC (NEO)
Data as of , from SEC Form 4 filings.
See up to 3 months of NEO. The 7-day demo opens the 1M and 3M ranges and puts NEO on your watchlist.
Start 7-day demoLatest NEO insider trades
About NEOGENOMICS INC (NEO)
NeoGenomics Inc provides oncology diagnostic testing and consultative services which include technical laboratory services and professional interpretation of laboratory test results by licensed physicians or molecular experts in pathology and oncology. The company operates a network of cancer-focused testing laboratories in the United States and the United Kingdom. The company operates in a single segment and derives revenue from clients by providing clinical cancer testing, interpretation, and consultative services, molecular and NGS testing, comprehensive technical and professional services offerings, clinical trials and research, validation laboratory services, and oncology data solutions.
- FORT MYERS, FL
- 2,500
- 1996
- XNAS
NEO Form 4 activity by transaction type, last 90 days
| Form 4 transaction type | Transactions | Shares | Total value |
|---|---|---|---|
| Open-market sale | 1 | 20,000 | $321K |
| Option exercise | 4 | 91,336 | |
| Tax withholding / forfeiture | 3 | 20,663 |
Dollar totals cover purchases and sales only (codes P and S). Grants, option exercises, gifts and tax withholding are counted in shares, because none of them is a trade at a market price.
NEO insider transactions (Form 4)
6569 Form 4 filings on record, the earliest from Nov 5, 2024, newest first. Filing history page 2 of 3.
| Date | Insider | Transaction | Security | Shares | Price | Value |
|---|---|---|---|---|---|---|
| Warren Stone - Officer | Open-market sale | Common Stock | 22,128 | $12.50 | $277K | |
| Warren Stone - Officer | Option exercise | Common Stock | 59,382 | $0.00 footnote F1 | - | |
| Warren Stone - Officer | Tax withholding / forfeiture | Common Stock | 15,127 footnote F2 | $0.00 | - | |
| ||||||
| Alicia C. Olivo - Officer | Option exercise | Common Stock | 59,382 | $0.00 footnote F1 | - | |
| Alicia C. Olivo - Officer | Tax withholding / forfeiture | Common Stock | 15,145 footnote F2 | $0.00 | - | |
| ||||||
| Warren Stone - Officer | Tax withholding / forfeiture | Common Stock | 8,776 footnote F1 | $0.00 | - | |
| ||||||
| Alicia C. Olivo - Officer | Option exercise | Common Stock | 8,977 | $10.05 | $90K | |
| Alicia C. Olivo - Officer | Open-market sale | Common Stock | 20,916 | $12.00 | $251K | |
| Alicia C. Olivo - Officer | Option exercise | Stock Option (Right to Buy) | 8,977 | $0.00 | - | |
| Alicia C. Olivo - Officer | Open-market sale | Common Stock | 4,918 | $10.00 | $49K | |
| Alicia C. Olivo - Officer | Tax withholding / forfeiture | Common Stock | 1,666 | $0.00 | - | |
 Jeffrey Scott Sherman - Officer | Open-market purchase | Common Stock | 20,000 | $5.62 | $112K | |
 Anthony P. Zook - Officer | Open-market purchase | Common Stock | 17,900 | $5.58 | $100K | |
| Alicia C. Olivo - Officer | Tax withholding / forfeiture | Common Stock | 14 | $0.00 | - | |
| Marjorie C. Green - Director | Grant or award | Stock Option (Right to Buy) | 16,019 | $0.00 | - | |
| Marjorie C. Green - Director | Grant or award | Restricted Stock Unit | 22,964 | $0.00 | - | |
| Felicia Williams - Director | Option exercise | Common Stock | 7,160 | $0.00 | - | |
| Felicia Williams - Director | Option exercise | Restricted Stock Unit | 7,160 | $0.00 | - | |
| Felicia Williams - Director | Grant or award | Stock Option (Right to Buy) | 16,107 | $0.00 | - | |
| Felicia Williams - Director | Grant or award | Restricted Stock Unit | 23,077 | $0.00 | - | |
| Stephen M. Kanovsky - Director | Option exercise | Common Stock | 12,254 | $0.00 | - | |
| Stephen M. Kanovsky - Director | Option exercise | Restricted Stock Unit | 12,254 | $0.00 | - | |
| Stephen M. Kanovsky - Director | Grant or award | Stock Option (Right to Buy) | 16,107 | $0.00 | - | |
| Stephen M. Kanovsky - Director | Grant or award | Restricted Stock Unit | 23,077 | $0.00 | - | |
| Michael Aaron Kelly - Director | Option exercise | Common Stock | 12,254 | $0.00 | - | |
| Michael Aaron Kelly - Director | Option exercise | Restricted Stock Unit | 12,254 | $0.00 | - | |
| Michael Aaron Kelly - Director | Grant or award | Stock Option (Right to Buy) | 16,107 | $0.00 | - | |
| Michael Aaron Kelly - Director | Grant or award | Restricted Stock Unit | 23,077 | $0.00 | - | |
| Lynn A. Tetrault - Director | Option exercise | Common Stock | 12,254 | $0.00 | - | |
| Lynn A. Tetrault - Director | Option exercise | Restricted Stock Unit | 12,254 | $0.00 | - | |
| Lynn A. Tetrault - Director | Grant or award | Stock Option (Right to Buy) | 16,107 | $0.00 | - | |
| Lynn A. Tetrault - Director | Grant or award | Restricted Stock Unit | 23,077 | $0.00 | - | |
| Elizabeth Floegel - Director | Option exercise | Common Stock | 12,254 | $0.00 | - | |
| Elizabeth Floegel - Director | Option exercise | Restricted Stock Unit | 12,254 | $0.00 | - | |
| Elizabeth Floegel - Director | Grant or award | Stock Option (Right to Buy) | 16,107 | $0.00 | - | |
| Elizabeth Floegel - Director | Grant or award | Restricted Stock Unit | 23,077 | $0.00 | - | |
| Neil Gunn - Director | Option exercise | Common Stock | 12,254 | $0.00 | - | |
| Neil Gunn - Director | Option exercise | Restricted Stock Unit | 12,254 | $0.00 | - | |
| Neil Gunn - Director | Grant or award | Stock Option (Right to Buy) | 16,107 | $0.00 | - | |
| Neil Gunn - Director | Grant or award | Restricted Stock Unit | 23,077 | $0.00 | - | |
| Anthony P. Zook - Officer | Option exercise | Common Stock | 12,254 | $0.00 | - | |
| Anthony P. Zook - Officer | Tax withholding / forfeiture | Common Stock | 3,424 | $0.00 | - | |
| Anthony P. Zook - Officer | Option exercise | Restricted Stock Unit | 12,254 | $0.00 | - | |
| David Brian Perez - Director | Option exercise | Common Stock | 12,254 | $0.00 | - | |
| David Brian Perez - Director | Option exercise | Restricted Stock Unit | 12,254 | $0.00 | - | |
| David Brian Perez - Director | Grant or award | Stock Option (Right to Buy) | 16,107 | $0.00 | - | |
| David Brian Perez - Director | Grant or award | Restricted Stock Unit | 23,077 | $0.00 | - | |
| Alison L. Hannah - Director | Option exercise | Common Stock | 12,254 | $0.00 | - | |
| Michael Aaron Kelly - Director | Open-market purchase | Common Stock | 5,000 | $7.60 | $38K | |
| Warren Stone - Officer | Option exercise | Common Stock | 9,613 | $0.00 | - | |
| Warren Stone - Officer | Tax withholding / forfeiture | Common Stock | 2,341 | $0.00 | - | |
| Warren Stone - Officer | Open-market purchase | Common Stock | 5,700 | $8.58 | $49K | |
| Warren Stone - Officer | Option exercise | Restricted Stock Unit | 9,613 | $0.00 | - | |
| Alicia C. Olivo - Officer | Option exercise | Common Stock | 6,503 | $0.00 | - | |
| Alicia C. Olivo - Officer | Tax withholding / forfeiture | Common Stock | 1,584 | $0.00 | - | |
| Alicia C. Olivo - Officer | Option exercise | Restricted Stock Unit | 6,503 | $0.00 | - | |
| Jeffrey Scott Sherman - Officer | Option exercise | Common Stock | 13,005 | $0.00 | - | |
| Jeffrey Scott Sherman - Officer | Tax withholding / forfeiture | Common Stock | 3,167 | $0.00 | - | |
| Jeffrey Scott Sherman - Officer | Option exercise | Restricted Stock Unit | 13,005 | $0.00 | - | |
| Lynn A. Tetrault - Director | Open-market purchase | Common Stock | 7,000 | $8.14 | $57K | |
| Stephen M. Kanovsky - Director | Open-market purchase | Common Stock | 4,000 | $7.78 | $31K | |
| Anthony P. Zook - Officer | Open-market purchase | Common Stock | 18,900 | $7.88 | $149K | |
| David Brian Perez - Director | Open-market purchase | Common Stock | 10,000 | $7.63 | $76K | |
| Neil Gunn - Director | Open-market purchase | Common Stock | 4,510 | $7.76 | $35K | |
| Jeffrey Scott Sherman - Officer | Open-market purchase | Common Stock | 20,000 | $7.51 | $150K | |
Recent NEO Form 144 notices of proposed sale
3An insider files Form 144 before selling restricted or control stock. It announces a planned sale. If the sale goes ahead, it shows up later on a Form 4.
| Filed | Filer | Relationship | Shares | Market value | Notice |
|---|---|---|---|---|---|
| GREG AUNAN | Officer | 20,000 | $321K | View on EDGAR | |
| - | - | - | - |
Stock trades in NEO disclosed by members of the U.S. House in the last 12 months, newest first. Values are the ranges as filed.
| Member | Type | Traded | Disclosed | Value range | Owner | Days to disclose | Filing |
|---|---|---|---|---|---|---|---|
 Gilbert Ray Cisneros, Jr.Democrat, CA-31 | Purchase |
NEO insider trading FAQ
What is the latest insider trade for NEO?
NEOGENOMICS INC (NEO) had 4 insider filings in the last 90 days, with the most recent on 2026-10-05. The full record for NEO runs to 69 Form 4 filings, the earliest from 2024-11-05. InsiderAlpha adds new Form 4, Form 144 and 8-K filings as they arrive from SEC EDGAR.
How many insiders are buying NEO stock?
No insider purchases of NEO were filed in the last 90 days. 10 purchases are on record for this company.
How many insiders are selling NEO stock?
1 insider sale of NEO was filed in the last 90 days, totaling $321K.
Where can I see NEO SEC filings (Form 4, 10-K, 10-Q, 8-K)?
This page collects NEO Form 4 insider transactions, Form 144 sale notices and 8-K filings in one place. Annual 10-K and quarterly 10-Q reports live on the company's SEC EDGAR page.
More Health Care companies with insider activity
Recent insider filings
10The EDGAR links open each original Form 4, so you can check any number on this page against the filing it came from.
- - Warren Stone view on EDGAR
- - Alicia C. Olivo view on EDGAR
- - Warren Stone view on EDGAR
- - Greg D. Aunan view on EDGAR
- - Carolyn S. Starrett view on EDGAR
- - Lynn A. Tetrault view on EDGAR
- - Lynn A. Tetrault view on EDGAR
- - John P. Kenny view on EDGAR
- - Felicia Williams view on EDGAR
Related companies with recent insider activity
Learn more
- Insider selling: signal or noise?
- Why most insider sales are routine, and the few patterns worth a second look.
- Form 144 vs Form 4
- A Form 144 announces a planned sale; the Form 4 reports it after it happens.
- Insider activity in Health Care
- Where NEO's peers are being bought and sold.
- Every recent Form 4
- The market-wide feed, updated as filings arrive from SEC EDGAR.
Follow NEO with a 7-day demo
- NEO on your watchlist
- Every NEO Form 4 filing on record
- Up to 3 months of NEO price history
- The daily trading plan of ranked insider buys, on a delay, with the plan archive
